Jamie Clark
Stock Analyst at Rothschild & Co
(2.40)
# 3,029
Out of 5,182 analysts
9
Total ratings
71.43%
Success rate
8.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $306.16 | +1.58% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $410.54 | +15.46% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $102.17 | +130.99% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $169.80 | +7.18% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $263.80 | +4.62% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $196.27 | -0.65% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $162.28 | +70.08% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $306.16
Upside: +1.58%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $410.54
Upside: +15.46%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $102.17
Upside: +130.99%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $169.80
Upside: +7.18%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $263.80
Upside: +4.62%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $196.27
Upside: -0.65%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $162.28
Upside: +70.08%